Skip to main content

Butcher Arthur C's Form 4 filing

Boston Scientific Corp (BSX) · filed Aug 26, 2024

Accession no.
0001225208-24-008198
Filed
Aug 26, 2024
Trade date
Aug 26, 2024
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.11M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Butcher Arthur CCIK 0001678249Officer (EVP& Grp Pres, MedSurg & APAC)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 26, 2024Common StockMOption exerciseAcquired+3,176$22.71+$72,126.9623,805Direct
Aug 26, 2024Common StockMOption exerciseAcquired+1,009$17.26+$17,415.3424,814Direct
Aug 26, 2024Common StockSSaleDisposed−14,012$79.25F2−$1,110,45110,802Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 26, 2024Common StockMOption exerciseDisposed−1,009$0.00$05,045Direct
Aug 26, 2024Common StockMOption exerciseDisposed−3,176$0.00$015,883Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $78.8970 to $79.5900, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)